Answer
Kidney function affects gefapixant exposure. Evidence is insufficient to recommend use in end-stage renal disease requiring dialysis.
Sources for this answer
- Lyfnua 45 mg film-coated tabletsemc · SmPC Current selected SmPC · Version 3
loading page…
Explore the tools and reference material available on iatroX.
Explore askiatroX